Melabon K (Paracetamol, Acetylsalicylic Acid, Caffeine)

Paracetamol reduces pain and fever by inhibiting central COX enzymes, lowering prostaglandin production in the brain. Acetylsalicylic acid irreversibly blocks COX‑1 and COX‑2, decreasing peripheral prostaglandins and thromboxanes, which adds analgesic, antipyretic and anti‑inflammatory activity. Caffeine blocks adenosine receptors, increasing neuronal firing and enhancing the analgesic effect of the other two agents while also providing a mild stimulant effect.

The appropriate dose of Melabon K is determined by a qualified healthcare professional based on the individual’s age, weight, medical history and the severity of symptoms. Because the product contains a fixed combination of three active ingredients, the prescriber will select the dosage that balances efficacy with safety for each patient.

The safety of Melabon K in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication, as the acetylsalicylic acid component may pose specific concerns.

To place an order, submit an enquiry on the Melabon K product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Standard paracetamol tablets contain only the analgesic/antipyretic component, whereas Melabon K adds acetylsalicylic acid for anti‑inflammatory action and caffeine to boost analgesic potency. This multicomponent formulation can produce faster and more pronounced pain relief for certain conditions, but it also carries additional considerations such as aspirin‑related bleeding risk and caffeine‑related stimulation.

Melabon K should be stored at ambient temperature below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children. Do not store in a refrigerator or freezer unless specifically instructed by the supplier.

Melabon K is intended for oral administration. Swallow the tablet whole with a full glass of water, preferably with food to reduce stomach irritation. Do not crush, chew, or split the tablet unless directed by a healthcare professional. Follow the dosing instructions provided by the prescriber and avoid exceeding the recommended amount.

Serious risks include gastrointestinal bleeding, severe allergic reactions such as anaphylaxis or skin rashes, liver toxicity especially with excessive use, and rare but life‑threatening skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as vomiting blood, severe abdominal pain, rash, or jaundice.

Melabon K should be avoided by individuals with known hypersensitivity to paracetamol, aspirin, or caffeine; those with active peptic ulcer disease or significant bleeding disorders; patients with severe liver or kidney impairment; and anyone who is pregnant without medical advice. Children under the recommended age limit and patients taking certain anticoagulants should also consult a physician before use.